Previous studies have indicated that epigenetic markers and collaborating transcription factors can be ascribed to androgen-independent prostate cancer, including histone markers, [30] FoxA1 [31, 32], MED1(Mediator complex subunit 1) [33] and FOXO1. The gene discussed is MED1; the disease is prostate cancer.